Puget Technologies (OTCBB:PUGE) revealed its subsidiary, Cannabis
Biotech, is placing a high focus on the isolation of terpenes and their
unique synergistic interaction. As part of its commitment to discovering
and developing the highest quality medical marijuana products, Cannabis
Biotech’s scientific team is exploring the benefits of terpenes.
In the cannabis plant, terpenes are responsible for delivering the
complex effects of the whole plant’s medicinal benefits and play a role
in its aroma and flavor. Terpenes are believed to interact
synergistically with cannabinoids to improve the efficacy of medical
marijuana. Cannabinoids are a group of compounds present in marijuana
and occur naturally in the nervous and immune systems of humans and
animals.
Kenneth Morrow, prominent international marijuana authority and terpene
research pioneer, is heading up Cannabis Biotech’s scientific team. He
said, “We look forward to investigating terpenes and discovering what
benefits they hold.” He added, “Terpene isolation could play a major
role in the development of the medical marijuana industry by improving
its effectiveness.”
Additional information about Cannabis Biotech can be found at http://www.cannabisbiotech.com.
About Puget Technologies (PUGE)
Puget Technologies is a publicly traded company on the OTCBB Market
stock exchange. Puget Technologies acquires, develops and sells leading
edge consumer oriented products ready for rapid commercialization.
Product lines under development include B-29 Energy Drinks and several
medical marijuana products through its subsidiary, Cannabis Biotech.
Much of Puget’s resources are dedicated to research and development to
provide consumers with quality options while meeting investor
expectations.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange act of
1934, as amended, including statements that include the words
"believes," "expects," "anticipates," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to differ materially from
those expressed or implied by such forward-looking statements. In
addition, description of anyone's past success, either financial or
strategic, is no guarantee of future success. This news release only
speaks as of the date of its distribution.
Copyright Business Wire 2013